Get notified when SMMT files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NASDAQ: SMMT Summit Therapeutics Inc. 8-K

Summit Therapeutics reports Q1 2026 financial results and operational progress

Filed April 30, 2026 · Period ending April 30, 2026 · ~1 min read

Key Changes

  • medium

    Summit announced first quarter 2026 financial results and operational updates through a press release. Specific financial figures and operational details are contained in the attached exhibit rather than the filing body.

    Item 2.02 verify on EDGAR →
  • low

    This is a routine quarterly earnings announcement filing. The 8-K serves as the formal notification mechanism, with substantive information provided in the press release exhibit.

    8-K: Earnings verify on EDGAR →

This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (FNGR 10-Q) is open in full — no account needed.

Partner

Trade SMMT commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?
View original filing on SEC.gov Press release (Ex 99.1) on EDGAR ↗

Source-verified from EDGAR · Narrative written by AI · Jun 2, 2026 · How we verify